These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3594587)

  • 1. [Changes in plasma binding of ortho-iodobenzoate and ortho-iodohippuran in patients with kidney and liver diseases].
    Láznícek M; Kvĕtina J; Mazák J; Krch V; Kvĕtinová M; Srámek B
    Cesk Farm; 1987 Apr; 36(3):97-102. PubMed ID: 3594587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Binding of 131I-hippuran by erythrocytes of healthy subjects and patients with kidney diseases].
    Degtereva OA; Emanuél' VL; Kozlov VV
    Urol Nefrol (Mosk); 1983; (4):49-51. PubMed ID: 6623752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protein binding of sulphachlorpiridacine (author's transl)].
    Mariño EL; Tabernero JM; Macías JG; Domínguez-Gil A; de Castro S
    Arch Farmacol Toxicol; 1979 Aug; 5(2):107-16. PubMed ID: 533316
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacological effect of nonsteroid anti-inflammatory agents and their interaction with blood plasma proteins].
    Lutsevich AN; Bender KI; Kupchikov VV
    Eksp Klin Farmakol; 1992; 55(2):68-74. PubMed ID: 1422462
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood kinetics of a low dose of iodoxamate.
    Arditi M; Molino G; Biondi A; Fornara A; Fava C; Bonati F
    Rays; 1985; 10(1):81-7. PubMed ID: 3843640
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of radioisotope technic for the determination of plasma volume (and blood) in liver and kidney diseases].
    Stajnfl S; Bosnjaković V; Savin S; Ristić M
    Med Pregl; 1970; 23(5):239-41. PubMed ID: 5206728
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kidney function test with the slope method and double labeling].
    Mostbeck A; Zimmermann E
    Wien Z Inn Med; 1968; 49(12):481-8. PubMed ID: 4982375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the binding between uric acid and plasma proteins (author's transl)].
    Sforza GR; Marcolongo R; Della Fazia L; Masciangelo F; Morozzi G; Lo Cosmo C
    Quad Sclavo Diagn; 1980 Dec; 15(4):1075-89. PubMed ID: 7454962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symposium on homeostasis in disease states. 1. Serum proteins].
    Anzai T
    Nihon Naika Gakkai Zasshi; 1970 Nov; 59(11):1156-61. PubMed ID: 5530672
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of bile salts on the binding of bilirubin by plasma proteins.
    Fulop M; Sandson J
    Clin Sci; 1967 Dec; 33(3):459-69. PubMed ID: 6082605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma gastrin concentration in normal subjects and in patients with stomach, liver, kidney and pancreatic diseases].
    Dörner M; Lackas S; Kaess H
    Verh Dtsch Ges Inn Med; 1972; 78():1409-11. PubMed ID: 4665563
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma proteins. A review.
    Simmons P; Penny R; Goller I
    Med J Aust; 1969 Sep; 2(10):494-506. PubMed ID: 4186516
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma protein binding substances].
    Maeda K
    Nihon Rinsho; 1984 Aug; 42(8):1838-44. PubMed ID: 6392606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on the question of toxicity of prolonged administration of cyclamate in patients with liver and kidney diseases].
    Zöllner N; Schnelle K
    Arzneimittelforschung; 1967 Dec; 17(12):1568-73. PubMed ID: 5632800
    [No Abstract]   [Full Text] [Related]  

  • 15. o- and M-iodohippurate binding to plasma proteins as a model drug transport mechanism.
    Láznícek M; Kvĕtina J
    J Pharm Pharmacol; 1984 Oct; 36(10):690-3. PubMed ID: 6150089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of d-tubocurarine plasma protein binding in health and disease.
    Walker JS; Shanks CA; Brown KF
    Anesth Analg; 1983 Oct; 62(10):870-4. PubMed ID: 6614519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in plasma proteins and drug distribution in kidney and liver diseases].
    Manojlović Z; Kopitar Z; Lenardic A; Plavsić F
    Lijec Vjesn; 1993; 115(11-12):366-9. PubMed ID: 8177001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective serum protein binding of ketoprofen in liver diseases.
    Sakai T; Maruyama T; Sako T; Ahmed S; Zuidema X; Fujiyama S; Otagiri M
    Enantiomer; 1999; 4(5):477-82. PubMed ID: 10586515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simplified determination of serum iron binding capacity in normal individual and patients with various types of diseases].
    Kitaguchi K; Nishimoto S; Nishikawa R
    Rinsho Byori; 1968 Jun; 16(6):525-30. PubMed ID: 5248091
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein binding of coumarin anticoagulants in disease states.
    Bachmann K; Shapiro R
    Clin Pharmacokinet; 1977; 2(2):110-26. PubMed ID: 324687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.